24 research outputs found

    Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

    Get PDF
    How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life-years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, for 359 diseases and injuries for 195 countries and territories over the past 28 years. Methods We used data for age-specific mortality rates, years of life lost (YLLs) due to premature mortality, and years lived with disability (YLDs) from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to calculate HALE and DALYs from 1990 to 2017. We calculated HALE using age-specific mortality rates and YLDs per capita for each location, age, sex, and year. We calculated DALYs for 359 causes as the sum of YLLs and YLDs. We assessed how observed HALE and DALYs differed by country and sex from expected trends based on Socio-demographic Index (SDI). We also analysed HALE by decomposing years of life gained into years spent in good health and in poor health, between 1990 and 2017, and extra years lived by females compared with males. Findings Globally, from 1990 to 2017, life expectancy at birth increased by 7路4 years (95% uncertainty interval 7路1-7路8), from 65路6 years (65路3-65路8) in 1990 to 73路0 years (72路7-73路3) in 2017. The increase in years of life varied from 5路1 years (5路0-5路3) in high SDI countries to 12路0 years (11路3-12路8) in low SDI countries. Of the additional years of life expected at birth, 26路3% (20路1-33路1) were expected to be spent in poor health in high SDI countries compared with 11路7% (8路8-15路1) in low-middle SDI countries. HALE at birth increased by 6路3 years (5路9-6路7), from 57路0 years (54路6-59路1) in 1990 to 63路3 years (60路5-65路7) in 2017. The increase varied from 3路8 years (3路4-4路1) in high SDI countries to 10路5 years (9路8-11路2) in low SDI countries. Even larger variations in HALE than these were observed between countries, ranging from 1路0 year (0路4-1路7) in Saint Vincent and the Grenadines (62路4 years [59路9-64路7] in 1990 to 63路5 years [60路9-65路8] in 2017) to 23路7 years (21路9-25路6) in Eritrea (30路7 years [28路9-32路2] in 1990 to 54路4 years [51路5-57路1] in 2017). In most countries, the increase in HALE was smaller than the increase in overall life expectancy, indicating more years lived in poor health. In 180 of 195 countries and territories, females were expected to live longer than males in 2017, with extra years lived varying from 1路4 years (0路6-2路3) in Algeria to 11路9 years (10路9-12路9) in Ukraine. Of the extra years gained, the proportion spent in poor health varied largely across countries, with less than 20% of additional years spent in poor health in Bosnia and Herzegovina, Burundi, and Slovakia, whereas in Bahrain all the extra years were spent in poor health. In 2017, the highest estimate of HALE at birth was in Singapore for both females (75路8 years [72路4-78路7]) and males (72路6 years [69路8-75路0]) and the lowest estimates were in Central African Republic (47路0 years [43路7-50路2] for females and 42路8 years [40路1-45路6] for males). Globally, in 2017, the five leading causes of DALYs were neonatal disorders, ischaemic heart disease, stroke, lower respiratory infections, and chronic obstructive pulmonary disease. Between 1990 and 2017, age-standardised DALY rates decreased by 41路3% (38路8-43路5) for communicable diseases and by 49路8% (47路9-51路6) for neonatal disorders. For non-communicable diseases, global DALYs increased by 40路1% (36路8-43路0), although age-standardised DALY rates decreased by 18路1% (16路0-20路2)

    Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Get PDF
    How long one lives, how many years of life are spent in good and poor health, and how the population's state of health and leading causes of disability change over time all have implications for policy, planning, and provision of services. We comparatively assessed the patterns and trends of healthy life expectancy (HALE), which quantifies the number of years of life expected to be lived in good health, and the complementary measure of disability-adjusted life-years (DALYs), a composite measure of disease burden capturing both premature mortality and prevalence and severity of ill health, for 359 diseases and injuries for 195 countries and territories over the past 28 years.; We used data for age-specific mortality rates, years of life lost (YLLs) due to premature mortality, and years lived with disability (YLDs) from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2017 to calculate HALE and DALYs from 1990 to 2017. We calculated HALE using age-specific mortality rates and YLDs per capita for each location, age, sex, and year. We calculated DALYs for 359 causes as the sum of YLLs and YLDs. We assessed how observed HALE and DALYs differed by country and sex from expected trends based on Socio-demographic Index (SDI). We also analysed HALE by decomposing years of life gained into years spent in good health and in poor health, between 1990 and 2017, and extra years lived by females compared with males. Globally, from 1990 to 2017, life expectancy at birth increased by 7路4 years (95% uncertainty interval 7路1-7路8), from 65路6 years (65路3-65路8) in 1990 to 73路0 years (72路7-73路3) in 2017. The increase in years of life varied from 5路1 years (5路0-5路3) in high SDI countries to 12路0 years (11路3-12路8) in low SDI countries. Of the additional years of life expected at birth, 26路3% (20路1-33路1) were expected to be spent in poor health in high SDI countries compared with 11路7% (8路8-15路1) in low-middle SDI countries. HALE at birth increased by 6路3 years (5路9-6路7), from 57路0 years (54路6-59路1) in 1990 to 63路3 years (60路5-65路7) in 2017. The increase varied from 3路8 years (3路4-4路1) in high SDI countries to 10路5 years (9路8-11路2) in low SDI countries. Even larger variations in HALE than these were observed between countries, ranging from 1路0 year (0路4-1路7) in Saint Vincent and the Grenadines (62路4 years [59路9-64路7] in 1990 to 63路5 years [60路9-65路8] in 2017) to 23路7 years (21路9-25路6) in Eritrea (30路7 years [28路9-32路2] in 1990 to 54路4 years [51路5-57路1] in 2017). In most countries, the increase in HALE was smaller than the increase in overall life expectancy, indicating more years lived in poor health. In 180 of 195 countries and territories, females were expected to live longer than males in 2017, with extra years lived varying from 1路4 years (0路6-2路3) in Algeria to 11路9 years (10路9-12路9) in Ukraine. Of the extra years gained, the proportion spent in poor health varied largely across countries, with less than 20% of additional years spent in poor health in Bosnia and Herzegovina, Burundi, and Slovakia, whereas in Bahrain all the extra years were spent in poor health. In 2017, the highest estimate of HALE at birth was in Singapore for both females (75路8 years [72路4-78路7]) and males (72路6 years [69路8-75路0]) and the lowest estimates were in Central African Republic (47路0 years [43路7-50路2] for females and 42路8 years [40路1-45路6] for males). Globally, in 2017, the five leading causes of DALYs were neonatal disorders, ischaemic heart disease, stroke, lower respiratory infections, and chronic obstructive pulmonary disease. Between 1990 and 2017, age-standardised DALY rates decreased by 41路3% (38路8-43路5) for communicable diseases and by 49路8% (47路9-51路6) for neonatal disorders. For non-communicable diseases, global DALYs increased by 40路1% (36路8-43路0), although age-standardised DALY rates decreased by 18路1% (16路0-20路2). With increasing life expectancy in most countries, the question of whether the additional years of life gained are spent in good health or poor health has been increasingly relevant because of the potential policy implications, such as health-care provisions and extending retirement ages. In some locations, a large proportion of those additional years are spent in poor health. Large inequalities in HALE and disease burden exist across countries in different SDI quintiles and between sexes. The burden of disabling conditions has serious implications for health system planning and health-related expenditures. Despite the progress made in reducing the burden of communicable diseases and neonatal disorders in low SDI countries, the speed of this progress could be increased by scaling up proven interventions. The global trends among non-communicable diseases indicate that more effort is needed to maximise HALE, such as risk prevention and attention to upstream determinants of health

    Systematic review and meta-analysis of the prevalence of anemia among pregnant Iranian women (2005 - 2015)

    Get PDF
    Context: Anemia is a common, global health problem that has short-term and long-term effects during pregnancy. Several studies have been conducted on the prevalence of anemia among pregnant Iranian women in the last 10 years (2005-2015). The current study evaluated the prevalence of anemia among pregnant Iranian women in this time period. EvidenceAcquisition: Thecurrent study followed the Preferred Reporting Items for systematic reviewsandmeta-analyses (PRISMA) checklist. Searches for relevant literature were conducted on scientific databases such as the Iranian journal database (Magiran), Iranian biomedical journal database (IranMedex), the scientific information database (SID), global medical article Limberly (Medlib), IranDoc, Scopus, PubMed, ScienceDirect, Springer, Web of Science, Wiley online library, and Google Scholar. All population-based studiesandnational surveys that reportedonthe prevalence of anemiaamongpregnant Iranianwomenpublished between January 1st, 2005 and December 31st, 2015 were included. All related articles were considered based on inclusion criteria. Using a random effects model, data were analyzed through STATA software (ver.11.1). Results: Eighteen articles with a combined sample size of 51,521 were investigated. The prevalence of anemia in pregnant Iranian women was estimated at 17.9 (CI: 95; 14.7 - 21.1). The highest and lowest percentages were reported in Iran鈥檚 central (24.9) and western (6.3) parts, respectively. The prevalence of anemia among rural (17.6) and urban (22.1) pregnant Iranian women was also determined. Conclusions: The prevalence of anemia among pregnant Iranian women has increased in the last 10 years. Therefore, appropriate intervention plans, including training in proper nutrition during pregnancy and training in the correct use of iron, vitamins, and folic acid supplements, should be arranged and performed in prenatal clinics or before marriage. 漏 2016, Shiraz University of Medical Sciences
    corecore